CTMX icon

CytomX Therapeutics

142 hedge funds and large institutions have $739M invested in CytomX Therapeutics in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

1% more funds holding

Funds holding: 141142 (+1)

12% less capital invested

Capital invested by funds: $843M → $739M (-$104M)

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.74M
Puts
$1.2M
Net Calls
Net Calls Change

Top Buyers

1 +$16.4M
2 +$14.9M
3 +$12.8M
4
Renaissance Technologies
Renaissance Technologies
New York
+$10.3M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.62M

Top Sellers

1 -$29M
2 -$7.54M
3 -$7.54M
4
PA
Perceptive Advisors
New York
-$6.56M
5
PC
PointState Capital
New York
-$4.38M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$134M
2
$74.3M
3
$73.8M
4
$48.4M
5
$43.9M
6
$39.1M
7
$32.3M
8
$16.7M
9
$14.9M
10
$12.8M
11
$12M
12
$11.9M
13
$10.5M
14
$10M
15
$9.03M
16
$8.3M
17
$8.27M
18
$8.08M
19
$7.63M
20
$6.92M
21
$6.56M
22
$6.27M
23
$6.06M
24
$6M
25
$5.65M